TY - JOUR
T1 - Clinical evaluation study of the German network of disorders of sex development (DSD)/Intersexuality
T2 - Study design, description of the study population, and data quality
AU - Lux, Anke
AU - Kropf, Siegfried
AU - Kleinemeier, Eva
AU - Jürgensen, Martina
AU - Thyen, Ute
N1 - Funding Information:
The Network Working Group: Dr. Akkurt, Hamburg; Dr. Albers, Oldenburg; Prof. Bartsch, Mainz; Dr. Becker, Frankfurt a. M.; Prof. Beckmann, Erlangen; Dr. Beetz, Mainz; Prof. Bettendorf, Heidelberg; Dr. Beyer, Ober-hausen; Dr. Binder, Tübingen; Prof. Boemers, Köln; Dr. Brack, Celle; Dr. Caliebe, Kiel; Prof. Dietz, München; Dobberphul, Neubrandenburg; Prof. Dörr, Erlangen; Prof. Eckholdt, Jena; Prof. Finke, Halle; Prof. Fisch, Hamburg; Dr. Flück, Bern; Prof. Frohneberg, Karlsruhe; Dr. Gätjen, Bremen; Dr. Gitter, Bremen; Prof. Grüters, Berlin; Prof. Hampel, Rostock; Prof. Hauffa, Essen; Prof. Heidemann, Augsburg; Dr. Heinz, Berlin; Dr. Hemmighaus, Herne; Prof. Hensen, Hannover; Prof. Hiort, Lübeck; Dr. Hofmann, Hannover; Dr. Höhne, Halle; Prof. Holterhus, Kiel; Prof. Hosie, München; Dr. Kapelari, Innsbruck; Prof. Karges, Aachen; Dr. Keller, Leipzig; Prof. Kiess, Leipzig; Dr. Köhler, Berlin; Dr. Körner, Leipzig; Dr. Korsch, Köln; PD Dr. Krege, Krefeld; Prof. Kuhnle-Krahl, München; Dr. l'Allemand-Jander, St. Gallen; Dr. Leriche, Ulm; Dr. Leube, Düsseldorf; Dr. Loeser, Endingen; Prof. Lorenz, Bremen; Dr. Marg, Bremen; Prof. Mau, Berlin; PD Dr. Mohnike, Magdeburg; Dr. Morlot, Hannover; Prof. Mullis, Bern; Prof. Part-sch, Esslingen; Prof. Pfäffle, Leipzig; Prof. Ranke, Tübingen; Dr. Rauch, Erlan- gen; PD Dr. Riccabona, Linz; Prof. PD Dr. Richter-Unruh, Bochum; PD Dr. Riepe, Kiel; Dr. Rohrer, Homburg; Dr. Roll, Mannheim; Prof. Rösch, Regensburg; Prof. Roth, Wuppertal; Salzgeber, Ulm; Dr. Schmidt, Lübeck; Prof. Schott, Erlangen; Dr. Schröder, Greifswald; Prof. Schwarz, München; Prof. von Schweinitz, München; Prof. Siemer, Homburg; Dr. Simic-Sch-leicher, Bremen; Prof. Sinnecker, Wolfsburg; Prof. Sippell, Kiel; Prof. Sohn, Frankfurt; Dr. Stein, Mainz; Dr. Tinschert, Dresden; Dr. Uhlarik, Hannover; Prof. Waag, Mannheim; Dr. Wabitsch, Ulm; Prof. Waldhauser, Wien; Prof. Wallwiener, Tübingen; Prof. Wessel, Mannheim; Prof. Westenfelder, Krefeld; Prof. Wieacker, Münster; Prof. Willig, Hamburg; Dr. Wintgens, Mönchengladbach; Prof. Wudy, Giessen; PD Dr. Wünsch, Lübeck; Dr. Wüsthof; Dr. Zeeh, Köln; Prof. Zöller, Göttingen The study was supported by the European Scientific Advisory Board: Sil-vano Bertelloni; Peggy T. Cohen-Kettenis, Ieuan A. Hughes, Claire Nihoul-Fékété, Martin Ritzén, Justine M. Schober.
Funding Information:
The rareness of a condition creates a serious challenge for research and patient care. Among approximately 30.000 diseases 5–7.000 are considered »rare« conditions with prevalence less than 1:2.000. Although rare, millions of people are affected worldwide but many lack access to specialized caregivers. The majority of conditions require extensive diagnostic procedures, ongoing symptomatic therapy and psychosocial support. Specific treatments often are not available and studies to promote evidence based treatment strategies are hampered by the heterogeneity of causes and clinical presentation, small numbers of individuals being treated in each centre, lack of incentives for the pharmaceutical companies to invest in research, and the lack of experience of the professionals involved. Therefore, the German Ministry of Education and Science (BMBF) has been funding ten disease-specific networks for rare diseases since 2003. Aim of this initiative is to promote national networks concerning research, specialized clinical and diagnostic centers and self-help and parent organizations.
PY - 2009
Y1 - 2009
N2 - Background. The German Network of Disorders of Sex Development (DSD)/Intersexuality carried out a large scale clinical evaluation study on quality of life, gender identity, treatment satisfaction, coping, and problems associated with diagnoses and therapies in individuals with disorders of sex development (DSD). DSD are a heterogeneous group of various genetic disorders of sex determination or sex differentiation, all of which are rare conditions. In about half of all cases the molecular genetic diagnosis is unknown and diagnosis rests on clinical features. Methods and design. The multi-centre clinical evaluation study includes short-term follow-up in some and cross-sectional assessments in all age and diagnostic groups fitting the criteria of DSD. Recruitment was from January 2005 until December 2007 in whole Germany and, additionally, in 2007 in Austria and German-speaking Switzerland. The study consists of a psychosocial inquiry for children, adolescents and their parents, and adults with standardized instruments and the collection of DSD-specific medical data by the attending physician. The main goal was the description of clinical outcomes and the health-care situation of individuals with DSD using a broad generic definition of DSD including all conditions with a mismatch of chromosomal, gonadal and phenotypical sex. 439 children and adolescents, their parents and adults with DSD participated. Discussion. The clinical evaluation study represents the most comprehensive study in this clinical field. The paper discusses the study protocol, the data management and data quality as well as the classification used, and it describes the study population. Given the lack of large datasets in rare conditions such as DSD and often biased results from small scale clinical case series, the study aims to generate concrete hypotheses for evidence-based guidelines, which should be tested in further studies.
AB - Background. The German Network of Disorders of Sex Development (DSD)/Intersexuality carried out a large scale clinical evaluation study on quality of life, gender identity, treatment satisfaction, coping, and problems associated with diagnoses and therapies in individuals with disorders of sex development (DSD). DSD are a heterogeneous group of various genetic disorders of sex determination or sex differentiation, all of which are rare conditions. In about half of all cases the molecular genetic diagnosis is unknown and diagnosis rests on clinical features. Methods and design. The multi-centre clinical evaluation study includes short-term follow-up in some and cross-sectional assessments in all age and diagnostic groups fitting the criteria of DSD. Recruitment was from January 2005 until December 2007 in whole Germany and, additionally, in 2007 in Austria and German-speaking Switzerland. The study consists of a psychosocial inquiry for children, adolescents and their parents, and adults with standardized instruments and the collection of DSD-specific medical data by the attending physician. The main goal was the description of clinical outcomes and the health-care situation of individuals with DSD using a broad generic definition of DSD including all conditions with a mismatch of chromosomal, gonadal and phenotypical sex. 439 children and adolescents, their parents and adults with DSD participated. Discussion. The clinical evaluation study represents the most comprehensive study in this clinical field. The paper discusses the study protocol, the data management and data quality as well as the classification used, and it describes the study population. Given the lack of large datasets in rare conditions such as DSD and often biased results from small scale clinical case series, the study aims to generate concrete hypotheses for evidence-based guidelines, which should be tested in further studies.
UR - http://www.scopus.com/inward/record.url?scp=65549123691&partnerID=8YFLogxK
U2 - 10.1186/1471-2458-9-110
DO - 10.1186/1471-2458-9-110
M3 - Journal articles
C2 - 19383134
AN - SCOPUS:65549123691
SN - 1471-2458
VL - 9
JO - BMC Public Health
JF - BMC Public Health
M1 - 110
ER -